Literature DB >> 16456108

Xanthine oxidase inhibition and heart failure: novel therapeutic strategy for ventricular dysfunction?

Roger J Hajjar, Jane A Leopold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16456108     DOI: 10.1161/01.RES.0000204557.09610.01

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  11 in total

Review 1.  Heart failure and loss of metabolic control.

Authors:  Zhao V Wang; Dan L Li; Joseph A Hill
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

2.  Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules.

Authors:  Toshio Ohtsubo; Kiyoshi Matsumura; Kanae Sakagami; Koji Fujii; Kazuhiko Tsuruya; Hideko Noguchi; Ilsa I Rovira; Toren Finkel; Mitsuo Iida
Journal:  Hypertension       Date:  2009-08-10       Impact factor: 10.190

3.  Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Authors:  Paul J M Wijnker; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

Review 4.  Berry-Derived Polyphenols in Cardiovascular Pathologies: Mechanisms of Disease and the Role of Diet and Sex.

Authors:  Rami S Najjar; Casey G Turner; Brett J Wong; Rafaela G Feresin
Journal:  Nutrients       Date:  2021-01-27       Impact factor: 5.717

5.  N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats.

Authors:  Tingting Wang; Shigang Qiao; Shaoqing Lei; Yanan Liu; Kwok F J Ng; Aimin Xu; Karen S L Lam; Michael G Irwin; Zhengyuan Xia
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

6.  Protective effect of Boerhaavia diffusa L. against mitochondrial dysfunction in angiotensin II induced hypertrophy in H9c2 cardiomyoblast cells.

Authors:  Ayyappan Prathapan; Vadavanath Prabhakaran Vineetha; Kozhiparambil Gopalan Raghu
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

Review 7.  Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies.

Authors:  Kwadwo Osei Bonsu; Isaac Kofi Owusu; Kwame Ohene Buabeng; Daniel Diamond Reidpath; Amudha Kadirvelu
Journal:  Ther Clin Risk Manag       Date:  2016-06-03       Impact factor: 2.423

8.  Kolaviron, a biflavonoid of Garcinia kola seed mitigates ischemic/reperfusion injury by modulation of pro-survival and apoptotic signaling pathways.

Authors:  Ademola Adetokunbo Oyagbemi; Dirk Bester; Johan Esterhuyse; Ebenezer Olatunde Farombi
Journal:  J Intercult Ethnopharmacol       Date:  2016-09-28

9.  Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure.

Authors:  Antoine H Chaanine; LeeAnn Higgins; Todd Markowski; Jarrod Harman; Maureen Kachman; Charles Burant; L Gabriel Navar; David Busija; Patrice Delafontaine
Journal:  Int J Mol Sci       Date:  2021-12-26       Impact factor: 6.208

Review 10.  Heart failure: novel therapeutic approaches.

Authors:  C Patel; S Deoghare
Journal:  J Postgrad Med       Date:  2015 Apr-Jun       Impact factor: 1.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.